跳至主要内容
临床试验/NCT06210230
NCT06210230已完成不适用

Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms

Zhejiang University1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2023年5月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
240
试验地点
1
主要终点
Change in blood lipids from baseline

研究概览

简要总结

Double-blind and placebo-controlled study on intervention effect of medium and long chain fatty acid triglyceride on glycolipid homeostasis in patients with metabolic syndrome and mechanisms

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed metabolic syndrome according to IDF diagnostic criteria;
  • Rarely eating out of home;
  • Aged between 40 and 70 years.

排除标准

  • Breastfeeding or pregnancy;
  • History of heart disease, coronary heart disease, stroke, cerebral infarction, viral liver disease (hepatitis A, hepatitis B, etc.), chronic kidney disease (GFR<60 ml/min) or cancer;
  • Diabetic ketoacidosis or hyperketosis;
  • Drug use has changed in the past six months;
  • Taking insulin;
  • Used MLCT edible oil in the past six months;
  • Have participated in other clinical trials in the last three months.

结局指标

主要结局

Change in blood lipids from baseline

时间窗: 6 months

The investigators will measure Triglycerides (TG), total cholesterol (TC), LDL-C, and HDL-C levels in blood samples before and after treatment.

Change in blood glucose from baseline

时间窗: 6 months

The investigators will measure HbA1c and fasting plasma glucose levels in blood samples before and after treatment.

次要结局

未报告次要终点

研究者

发起方
Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yu Zhang

Professor

Zhejiang University

研究点 (1)

Loading locations...

相似试验